India has imposed anti-dumping duties on monoisopropylamine (MIPA) imports from China, a key chemical intermediate used in pharmaceuticals, agrochemicals, and specialty chemicals. This move aims to protect domestic manufacturers from unfair trade practices and is expected to reshape sourcing dynamics for overseas buyers reliant on Chinese MIPA supply.
Regulatory action
India's Directorate General of Trade Remedies (DGTR) has imposed anti-dumping duties on monoisopropylamine (MIPA) imports from China. The measure is designed to protect domestic chemical manufacturers from unfair trade practices, specifically targeting Chinese-origin MIPA that may be sold at below-market prices.
Product significance
Monoisopropylamine is an important chemical intermediate used in various industrial applications, including the production of pharmaceuticals, agrochemicals, and specialty chemicals. Its role in downstream manufacturing makes this trade action relevant for global buyers in these sectors.
Market impact
This action is set to benefit Indian specialty chemical companies, including those in the amines sector, by improving market competitiveness and creating opportunities for increased domestic market share. Overseas importers who previously sourced MIPA from China may need to evaluate alternative suppliers or adjust procurement strategies.
What buyers should watch
Foreign buyers of monoisopropylamine should monitor Indian market developments closely. The duties may lead to price adjustments or supply shifts in the global MIPA market. Companies with supply chains dependent on Chinese MIPA should assess potential cost increases and explore diversification options, including Indian producers who may gain competitiveness.
Source: Read the original report | Published: June 11, 2026